Strategic Investment Solutions’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.5K Hold
80
﹤0.01% 414
2026
Q1
$12.2K Hold
80
﹤0.01% 401
2025
Q4
$11K Hold
80
﹤0.01% 390
2025
Q3
$10.3K Hold
80
﹤0.01% 374
2025
Q2
$9.68K Hold
80
﹤0.01% 368
2025
Q1
$8.92K Hold
80
﹤0.01% 382
2024
Q4
$7.79K Hold
80
﹤0.01% 412
2024
Q3
$9.2K Hold
80
﹤0.01% 370
2024
Q2
$6.84K Buy
+80
New +$8.03K ﹤0.01% 387
2023
Q4
$8.08K Sell
80
-4,960
-98% -$479K ﹤0.01% 789
2023
Q3
$512K Buy
5,040
+4,960
+6,200% +$503K 0.01% 391
2023
Q2
$7.77K Hold
80
﹤0.01% 590
2023
Q1
$7.36K Buy
+80
New +$6.99K ﹤0.01% 691

Other funds holding NVS

Strategic Investment Solutions's NVS Position: Q2 2026 in Review

Strategic Investment Solutions held its Novartis (NVS) position steady in Q2 2026 at 80 shares worth $12.5K. The position accounts for ﹤0.01% of the portfolio, ranked #414.

Strategic Investment Solutions first reported a position in NVS in Q1 2023 and has held it in 13 quarters since. The position peaked at $512K in Q3 2023. 1,611 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Strategic Investment Solutions held 80 shares of Novartis worth $12.5K as of Q2 2026.
  • Strategic Investment Solutions left its Novartis share count unchanged in Q2 2026.
  • Novartis made up ﹤0.01% of Strategic Investment Solutions's portfolio in Q2 2026, its #414 holding.
  • Strategic Investment Solutions first reported a position in Novartis in Q1 2023 and has held it in 13 quarters since.
  • Strategic Investment Solutions's Novartis position peaked at $512K in Q3 2023.
  • 1,611 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Strategic Investment Solutions's 13F filing for Q2 2026, filed 8 Jul 2026.